Abstract
Background
Being overweight for kidney transplant recipients can cause serious side effects. Weight gain affects two-thirds of kidney transplant recipients and has been attributed to a more liberal diet after transplantation, recovery of appetite due to lack of uremic toxicity, corticosteroid use, and inadequate lifestyle changes. The aim of this study was to assess gender-dependent profile of body mass index (BMI) changes after kidney transplantation (KTx).
Material/Methods
Sixty-two kidney transplant recipients (38 males and 24 females), aged 46.0±12.8 years at KTx, were observed according to weight gain after KTx. BMI was calculated before transplantation (pre-KTx) and at 6, 12, and 24 months post-KTx.
Results
During the 24-month observation period, we found an increase in the incidence of kidney transplant recipients being overweight or obese (pre-KTx 43.5% increase and 24-month post-Ktx 61.3% increase, P=0.036). We analyzed a number of factors that could potentially influence a 24-month BMI gain including age at KTx, gender, pre-KTx BMI, time on dialysis, pre-KTx glucose metabolism disorder, and post-KTx diabetes mellitus. For female recipients, there was a significant step-wise post-KTx increase in BMI during the 24-month observation period. The overall pre-KTx to 24-month net increase for female BMI was 2 times greater than that observed for male recipients (1.90±2.20 kg/m2 versus 0.89±1.85 kg/m2, P<0.001).
Conclusions
Weight gain after KTx was observed in both sexes, but the net BMI increase was more than 2 times greater in females than in males at 24-months post-KTx. This indicated the need for diet education and strict weight control in kidney transplant recipients, especially in female patients.
MeSH Keywords: Kidney Transplantation, Obesity, Overweight, Weight Gain
Background
Kidney transplantation (KTx) is the most preferential treatment for end stage renal disease patients, with prolonged life expectancy, lower morbidity, and better quality of life. An increase in body weight after KTx in kidney recipients is challenging [1,2]. In general, the epidemic of obesity is reflected in the KTx population, where the proportion of recipients with a body mass index (BMI) greater than of 30 kg/m2 is doubling every 15 years [3–5]. Prevalence of weight gain and obesity in kidney transplant recipients was observed in the first year after transplantation [6–10]. Ryan et al. reported the 10% to 35% average patient post-KTx weight gain [11]. Among the probable factors significantly contributing to increased body weight after KTx was the use of immunosuppressive drugs. Another probable cause was the non-uremic state of kidney transplant recipients, which may lead to increased energy intake [11]. Many reports have shown that transplant recipients do not implement lifestyle modification with adequate levels of physical activity. Lifestyle changes are difficult to make and require strong motivation [11–16].
Excessive weight gain resulting in being overweight or obese may be a detrimental complication in kidney transplant recipients; other detrimental complications include metabolic syndrome and new-onset diabetes after transplantation (NODAT), as well as cardiovascular diseases. These complication are the most important causes of morbidity and mortality after KTx [17–20]. Being overweight before transplantation correlates with insulin resistance after transplantation and is a risk factor for NODAT, so treatment for obesity may be a reasonable target for post-transplantation intervention [21]. Several published studies have shown that the cumulative incidence of obesity in transplant recipients is up to 10-fold higher than that reported in the non-transplanted population [21,22].
The aim of the present study was to assess the profile of BMI pre-KTx and at 6-months, 12-months, and 24-months post-KTx. Furthermore, we investigated the influence of age, gender, and dialysis modality on BMI changes.
Material and Methods
Our study included 62 Kidney transplant recipients (38 males and 24 females) from the Outpatient Clinic of Wrocław University Hospital, Poland. Study patients were observed for weight changes after KTx (Table 1). We analyzed a number of factors that could potentially influence a 24-month BMI gain, including age at KTx, gender, pre-KTx BMI, time on dialysis, pre-KTx glucose metabolism disorder, and post-KTx diabetes mellites.
Table 1.
Study group characteristics.
| Females (n=24) | Males (n=38) | p | |
|---|---|---|---|
| Age at KTx (years) | 45.0±12.5 | 46.6±13.2 | 0.600 |
| Original diagnosis | |||
| Polycystic kidney disease | 4 | 6 | |
| Glomerulonephritis | 14 | 25 | |
| Hypertensive nephropathy | 5 | 6 | |
| Other or unknown | 1 | 1 | |
| HD/PD | 18/6 | 32/6 | 0.283 |
| Time on dialysis [months](median and range) | 33 (21.5–60.5) | 29 (20–59) | 0.418 |
| Weight pre-KTx [kg] (mean±SD) [kg] | 64.3±13.7 | 76.5±12.1 | |
| BMI pre-KTx (mean±SD) [kg/m2] | 24.17±4.68 | 25.10±3.39 | 0.368 |
| Deceased donor/Living donor | 24/0 | 35/3 | |
| Immunosuppressive protocol: CsA/Tac | 2/22 | 7/31 | |
| Post-transplant DM (NODAT) (%) | 2/22 (9) | 6/32 (18.75) | 0.329 |
| Acute Rejection (AR) | 5/19 | 1/37 | 0.029 |
| Cytomegalovirus disease (CMV) | 5/19 | 13/25 | 0.201 |
| Pre-KTx GMD(−): BMI gain [kg/m2] (mean±SD) | 2.40±2.17 | 1.08±2.02 | 0.061 |
| Pre-KTx GMD(+): BMI gain [kg/m2] (mean±SD) | 0.67±1.87 | 0.65±1.65 | 0.977 |
The patient characteristics of the study groups is presented in Table 1. The mean age of study participants was 46.0±12.8 years at transplantation, and follow-up was greater than 2 years. Of these patients, 81% (n=50) underwent hemodialysis and 19% (n=12) underwent peritoneal dialysis pre-KTx. BMI was calculated as the dry weight in kilograms divided by the height in meters squared (kg/m2), and BMI was categorized according to World Health Organization guidelines as follows: underweight (<18.5 kg/m2), normal weight (18.5 to 24.9 kg/m2), overweight (25 to 29.9 kg/m2), and obese (>30 kg/m2). All the participants gave their informed consent. The research was approved by the Bioethics Committee of Wrocław Medical University, Poland. The statistical analysis was performed with Statistica v13 (Statsoft, Poland). The variables were tested for normality and are presented as mean ± standard deviation (SD) and range. The groups were compared with t-test for independent or independent normally distributed variables and Mann-Whitney or Wilcoxon tests in the other cases. The differences in frequencies were tested with Fisher exact test. The P value <0.05 was considered statistically significant. The study was supported by the Wrocław statutory funds (ST.C160.17.021).
Results
The study group included 62 kidney transplant recipients (24 females and 38 males) who did not differ in terms of pre-KTx BMI (P=0.368). In our clinic, patients post-KTx were treated with 2 main immunosuppressive protocols as described previously [23]. The protocols included: 1) combination of cyclosporin A (CsA) with mycophenolate mofetil/mycophenolate sodium (MMF/MPA) and corticosteroids (CS), or more frequently 2) combination of tacrolimus (TAC) with MMF/MPA and CS. In the CsA group the steroid administration was as follows: perioperative intravenous (IV) bolus of methylprednisolone 500 mg, followed by 250 mg IV (12 hours and 24 hours post-KTx), and 125 mg IV at day 2. From day 3, prednisone was given orally with the initial dose of prednisone 0.5 mg/kg body weight per day (but no more than 40 mg/day), and then the dose was tapered to reach 10 mg/day after 3 months and 5 mg after 6 months. In the TAC group, significantly smaller steroid doses were given: perioperative bolus of methylprednisolone 500 mg IV bolus, followed by 250 mg IV at day 1, and 125 mg IV at day 2. Since day 3, prednisone was given orally in the fixed dose of 20 mg. After 1 month, the prednisone dose was reduced to reach a daily dose of 15 mg, and then tapered to 10 mg after 2 months and 5 mg after 3 months. The mean yearly cumulative prednisone dose in cyclosporine-receiving patients was about 5600 mg compared with about 3000 mg in TAC-treated recipients. In high immunological risk patients’ induction therapy with thymoglobulin (high risk) and anti-CD25 antibody (moderate risk) were introduced with a combination of TAC, MMF/MPA, and CS. There was no steroid withdrawal protocol after kidney transplant recipients [23]. During the 24-month observation period we observed an increase in the incidence of overweight BMI and obesity BMI in our study group (pre-KTx was 43.5%, and 24-month post-KTx was 61.3%, P=0.036).
For female recipients, there was a significant step-wise post-KTx increase in BMI during the 24-month observation period (P<0.001). The BMI increased also in male recipients, however, to a lesser extent (P=0.005). The overall 24-month net BMI increase in female recipients was 2 times that observed for male recipients (1.90±2.20 kg/m2 versus 0.89±1.85 kg/m2, P<0.001). However, the gender related difference in 24-month BMI gain did not reach statistical significance (P=0.057). Of the 62 kidney transplant recipients (24 females and 38 males), 9 recipients developed NODAT (6 males and 3 females).
None of the other studied factors were proven in multivariate analysis to directly influence the post-KTx BMI gain, however, our results suggested that both female gender and no history of pre-KTx glucose metabolism disorder could be related to an increased BMI gain post-KTx Detailed data are shown in Table 2.
Table 2.
Post-transplant BMI profile.
| Pre-KTx* | p-Value pre-KTx vs. 6th month | 6th month | p-Value 6th vs. 12th month | 12th month | p-Value 12th vs. 24th month | 24th month | p-Value pre-KTx vs. 24th month | |
|---|---|---|---|---|---|---|---|---|
| Females | 24.17±4.68 | 0.032 | 25.01±4.94 | 0.017 | 25.51±5.26 | 0.008 | 26.07±5.05 | <0.001 |
| Males | 25.10±3.39 | 0.324 | 25.37±3.45 | 0.062 | 25.60±3.32 | 0.006 | 25.99±3.61 | 0.005 |
| p-value Females vs. Males | 0.368 | 0.741 | 0.933 | 0.943 |
KTx – kidney transplant.
Discussion
Kidney transplantation (KTx), unquestionably, is the most effective method of renal replacement therapy that improves graft survival [24–26], quality of life [27], and reduces medical costs [27,28]. Unfortunately, many studies have indicated that kidney transplant recipients continue to have increased mortality compared with the general population [11]. The present study demonstrated that the post-KTx weight gain increased in both males and females. Importantly, weight gain at 24-month follow-up was shown to be more than 2 times greater in females than in males. This tendency, especially in females, represents a major problem complicating post-KTx patient care, which deserves active prevention. Many published studies have shown that obesity after KTx decreases quality of life and significantly decreases graft survival [30].
Increased weight gain in female patients after KTx may be caused by more free time after KTx. Gętek et al. showed that male KTx patients were more likely than female KTX patients after KTx to assess the possibility of employment, accept their own appearance, and lead a normal lifestyle [31]. This suggests that after KTx female patients may be more likely to give up on work aspirations, and spend more time at home. Bad nutrition, poor diet, or lack of compliance with nutritional recommendations due to free time may contribute to the increased weight gain after KTx.
There are no current clinical guidelines that would be helpful to prevent, detect, or manage weight gain and obesity post-KTx [11]. There is a need to develop therapeutic strategies that would be helpful to minimize or prevent weight gain resulting in overweight BMI or obesity BMI in kidney transplant recipients. Further research is needed to assess nutrition interventions, lifestyle modifications, educational elements, and physical activity promotions [32].
The apparent greater weight gain and BMI increases in female patients compared to male patients was not statistically significant, which may be related to the small number of study patients. The problem of weight gain related to gender requires further investigation in larger group of kidney transplant recipients.
Conclusions
Post-transplantation weight increased after KTx in both males and females; in the 24-month follow-up period, the net BMI increase was more than 2 times greater in females (P<0.001). However, the gender related difference in 24-month BMI gain did not reach statistical significance (P=0.057). None of the factors in our multivariate analysis was proven to directly influence post-transplantation BMI gain. However, our results suggest that both female gender and no history of pre-transplantation glucose metabolism disorder could be related to an increased BMI gain after KTx. This results indicated the need for diet education, lifestyle modification, and strict weight control in kidney transplant recipients, especially in female patients.
Footnotes
Source of support: The study was supported by the Wrocław Medical University statutory funds (ST.C160.17.021)
References
- 1.Costa B, Moratelli L, Silva LB, et al. Body mass index in the first year after kidney transplantation. Transplant Proc. 2014;46(6):1750–52. doi: 10.1016/j.transproceed.2014.05.021. [DOI] [PubMed] [Google Scholar]
- 2.Fernandes JF, Leal PM, Rioja S, et al. Adiposity and cardiovascular disease risk factors in renal transplant recipients: Are there differences between sexes? Nutrition. 2013;29(10):1231–36. doi: 10.1016/j.nut.2013.03.019. [DOI] [PubMed] [Google Scholar]
- 3.Lentine KL, Delos Santos R, Axelrod D, et al. Obesity and kidney transplant candidates: How big is too big for transplantation? Am J Nephrol. 2012;36:575–86. doi: 10.1159/000345476. [DOI] [PubMed] [Google Scholar]
- 4.Friedman AN, Miskulin DC, Rosenberg IH, et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis. 2003;41:480–87. doi: 10.1053/ajkd.2003.50059. [DOI] [PubMed] [Google Scholar]
- 5.Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12:62–66. doi: 10.1038/nm0106-62. [DOI] [PubMed] [Google Scholar]
- 6.Jaggers HJ, Allman MA, Chan M. Changes in clinical profile and dietary considerations after renal transplantation. J Ren Nutr. 1996;6(1):12–20. [Google Scholar]
- 7.Johnson CP, Gallagher-Lepak S, Zhu YR, et al. Factors influencing weight gain after renal transplantation. Transplantation. 1993;56(4):822–26. doi: 10.1097/00007890-199310000-00008. [DOI] [PubMed] [Google Scholar]
- 8.Teplan V, Poledne R, Schück O, et al. Hyperlipidemia and obesity after renal transplantation. Ann Transplant. 2001;6(2):21–23. [PubMed] [Google Scholar]
- 9.Moore LW, Gaber AO. Patterns of early weight change after renal transplantation. J Ren Nutr. 1996;6(1):21–25. [Google Scholar]
- 10.Orazio L, Chapman J, Isbel NM, Campbell KL. Nutrition care for renal transplant recipients: An evaluation of service delivery and outcomes. J Ren Care. 2014;40(2):99–106. doi: 10.1111/jorc.12055. [DOI] [PubMed] [Google Scholar]
- 11.Ryan KJ, Segedin JM, Mash LE, et al. The effect of intensive nutrition interventions on weight gain after kidney transplantation: Protocol of a randomized controlled trial. BMC Nephrol. 2014;15:148. doi: 10.1186/1471-2369-15-148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Heinbokel T, Floerchinger B, Schmiderer A, et al. Obesity and its impact on transplantation and alloimmunity. Transplantation. 2013;96(1):10–16. doi: 10.1097/TP.0b013e3182869d2f. [DOI] [PubMed] [Google Scholar]
- 13.Orazio L, Hickman I, Armstrong K, et al. Higher levels of physical activity are associated with a lower risk of abnormal glucose tolerance in renal transplant recipients. J Ren Nutr. 2009;19(4):304–13. doi: 10.1053/j.jrn.2008.11.006. [DOI] [PubMed] [Google Scholar]
- 14.Nielens H, Lejeune TM, Lalaoui A, et al. Increase of physical activity level after successful renal transplantation: A 5year follow-up study. Nephrol Dial Transplant. 2001;16(1):134–40. doi: 10.1093/ndt/16.1.134. [DOI] [PubMed] [Google Scholar]
- 15.Zelle DM, Kok T, Dontje ML, et al. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013;27(4):E484–90. doi: 10.1111/ctr.12149. [DOI] [PubMed] [Google Scholar]
- 16.Hill CJ, Cardwell CR, Maxwell AP, et al. Obesity and kidney disease in type 1 and 2 diabetes: An analysis of the National Diabetes Audit. QJM. 2013;106:933–42. doi: 10.1093/qjmed/hct123. [DOI] [PubMed] [Google Scholar]
- 17.Luk AOY, So WY, Ma RCW, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes – a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care. 2008;31:2357–61. doi: 10.2337/dc08-0971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Massy ZA, Kasiske BL. Post-transplant hyperlipidemia: Mechanisms and management. J Am Soc Nephrol. 1996;7:971–77. doi: 10.1681/ASN.V77971. [DOI] [PubMed] [Google Scholar]
- 19.Aakhus S, Dahl K, Wideroe TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant. 1999;14:648–54. doi: 10.1093/ndt/14.3.648. [DOI] [PubMed] [Google Scholar]
- 20.Chakkeraa HA, Weil EJ, Pham PT, et al. Can new onset diabetes after kidney transplant be prevent? Diabetes Care. 2013;36:1406–12. doi: 10.2337/dc12-2067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Jindal RM, Sidner RA, Milgrom ML. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf. 1997;16:242–57. doi: 10.2165/00002018-199716040-00002. [DOI] [PubMed] [Google Scholar]
- 22.Weir MR, Fink JC. Risk for post-transplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34:1–13. doi: 10.1016/s0272-6386(99)70101-0. [DOI] [PubMed] [Google Scholar]
- 23.Hap K, Madziarska K, Zmonarski S, et al. Pre-transplantation oral glucose tolerance test can prevent post-transplant diabetes mellitus after renal transplantation; Preliminary study. Transplant Proc. 2018;50:1776–80. doi: 10.1016/j.transproceed.2018.03.125. [DOI] [PubMed] [Google Scholar]
- 24.McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991–2001. Nephrol Dial Transplant. 2002;17(12):2212–19. doi: 10.1093/ndt/17.12.2212. [DOI] [PubMed] [Google Scholar]
- 25.Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30. doi: 10.1056/NEJM199912023412303. [DOI] [PubMed] [Google Scholar]
- 26.Laupacis A, Keown PNP, Krueger H, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235–42. doi: 10.1038/ki.1996.307. [DOI] [PubMed] [Google Scholar]
- 27.Howard K, Salkeld G, White S, et al. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology. 2009;14(1):123–32. doi: 10.1111/j.1440-1797.2008.01073.x. [DOI] [PubMed] [Google Scholar]
- 28.Haller M, Gutjahr G, Kramar R, et al. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant. 2011;26(9):2988–95. doi: 10.1093/ndt/gfq780. [DOI] [PubMed] [Google Scholar]
- 29.van Walraven C, Manuel DG, Knoll G. Survival trends in ESRD patients compared with the general population in the United States. Am J Kidney Dis. 2013;63(3):491–99. doi: 10.1053/j.ajkd.2013.09.011. [DOI] [PubMed] [Google Scholar]
- 30.Nicoletto BB, Fonseca NK, Manfro RC, et al. Effects of obesity on kidney transplantation outcomes: A systematic review and meta-analysis. Transplantation. 2014;98(2):167–76. doi: 10.1097/TP.0000000000000028. [DOI] [PubMed] [Google Scholar]
- 31.Gętek M, Nowakowska-Zajdel E, Czech N, et al. Quality of life of patients on dialysis and after renal transplantation. Ann Acad Med Siles. 2010;64:23–30. [Google Scholar]
- 32.Klaassen G, Zelle DM, Navis GJ, et al. Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation: Design of the active care after transplantation (ACT) randomized controlled trial. BMC Nephrol. 2017;18(1):296. doi: 10.1186/s12882-017-0709-0. [DOI] [PMC free article] [PubMed] [Google Scholar]